华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688639 华恒生物

已收盘 12-23 15:00:00

{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":32.09,"timestamp":1734937200000,"preClose":33.47,"halted":0,"volume":5117697,"delay":0,"floatShares":227999999,"shares":250000000,"eps":1.1974,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.38,"latestTime":"12-23 15:00:00","open":33.1,"high":33.2,"low":32,"amount":166000000,"amplitude":0.0359,"askPrice":32.09,"askSize":1,"bidPrice":32.06,"bidSize":89,"shortable":0,"etf":0,"ttmEps":1.1974,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"adjPreClose":33.47,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":36.82,"lowLimit":30.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":249723997,"pbRate":4.31,"roa":"--","roe":"9.14%","epsLYR":2.84,"committee":0.191011,"marketValue":8014000000,"floatMarketCap":7328000000,"peRate":26.799733,"changeRate":-0.0412,"turnoverRate":0.0224,"status":1,"afterMarket":{"amount":0,"volume":0,"close":32.09,"buyVolume":0,"sellVolume":0,"time":1734939238975,"indexStatus":"已收盘 12-23 15:30:00","preClose":33.47}},"requestUrl":"/m/hq/s/688639","defaultTab":"news","newsList":[{"id":"2493978018","title":"华恒生物(688639.SH)：初步确定询价转让价格为31.89元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493978018","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493978018?lang=zh_cn&edition=full","pubTime":"2024-12-23 16:07","pubTimestamp":1734941227,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)披露股东询价转让定价情况，根据2024年12月23日询价申购情况，初步确定的本次询价转让价格为31.89元/股。本次询价转让拟转让股份已获全额认购，初步确定受让方为2家机构投资者，拟受让股份总数为335.78万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2492098444","title":"华恒生物(688639.SH)股东睿合远拟询价转让1.34%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492098444","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492098444?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:50","pubTimestamp":1734706208,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)披露股东询价转让计划，本次询价转让的股东为宁波睿合远创业投资合伙企业(有限合伙);出让方拟转让股份的总数为335.78万股，占华恒生物总股本的比例为1.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2492449632","title":"华恒生物最新公告：股东宁波睿合远拟询价转让335.78万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492449632?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:07","pubTimestamp":1734703620,"startTime":"0","endTime":"0","summary":"华恒生物公告，股东宁波睿合远创业投资合伙企业（有限合伙）拟通过询价转让方式转让其所持有的公司股份335.78万股，占公司总股本的1.34%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000042732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2492445416","title":"华恒生物：本次拟询价转让1.34%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492445416","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492445416?lang=zh_cn&edition=full","pubTime":"2024-12-20 21:30","pubTimestamp":1734701411,"startTime":"0","endTime":"0","summary":"格隆汇12月20日丨华恒生物(688639.SH)公布，拟参与华恒生物首发前股东询价转让（以下简称“本次询价转让”）的股东为宁波睿合远创业投资合伙企业（有限合伙）；出让方拟转让股份的总数为3,357,844股，占华恒生物总股本的比例为1.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220213020ab8744a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220213020ab8744a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2492710319","title":"华恒生物跌5% 18家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2492710319","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492710319?lang=zh_cn&edition=full","pubTime":"2024-12-19 14:46","pubTimestamp":1734590762,"startTime":"0","endTime":"0","summary":"12月19日，华恒生物股价大幅下跌，截至14点46分，华恒生物下跌5.02%，报33.70元/股，成交1.70亿元，换手率2.18%，振幅4.62%。资金动向截止发稿，华恒生物获得主力净流出514万元，其中超大单流出742万元，大单流入229万元。主营业务及业绩华恒生物公司主营业务为氨基酸及其衍生物产品研发、生产、销售。最新财报显示，今年三季报，华恒生物实现营业收入15.39亿元，同比增长12.82%，净利润为1.70亿元，同比减少46.90%，基本每股收益为0.74元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219144612ab83c355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219144612ab83c355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2490648228","title":"华恒生物创近1月新高获增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490648228","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490648228?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:49","pubTimestamp":1733881783,"startTime":"0","endTime":"0","summary":"12月11日，华恒生物股价大幅上涨，截至09点49分，华恒生物上涨5.08%，报37.84元/股，创近1个月新高，成交1.09亿元，换手率1.28%，振幅5.36%。资金动向截止发稿，华恒生物获得主力净流出343万元，其中超大单流出373万元，大单流入30万元。最新财报显示，今年三季报，华恒生物实现营业收入15.39亿元，同比增长12.82%，净利润为1.70亿元，同比减少46.90%，基本每股收益为0.74元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211094949ab6e29cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211094949ab6e29cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2488565259","title":"华恒生物股东减持进展：已减22万股，剩余425万股待减","url":"https://stock-news.laohu8.com/highlight/detail?id=2488565259","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488565259?lang=zh_cn&edition=full","pubTime":"2024-12-01 18:07","pubTimestamp":1733047620,"startTime":"0","endTime":"0","summary":"截至2024年11月29日，马鞍山基石已通过集中竞价方式减持22万股，占总股本的0.14%。减持期间的股价区间为76.45元至100.66元，总金额为2008万元。减持后，马鞍山基石的持股数量降至512万股，占公司总股本的2.05%。本次减持计划未能完全实施，仍有425万股未减持。2024年前三季度，华恒生物实现收入15.39亿元，归母净利润1.70亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241201182830abecd45f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241201182830abecd45f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2488654685","title":"12月1日华恒生物发布公告，其股东减持22.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488654685","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488654685?lang=zh_cn&edition=full","pubTime":"2024-12-01 18:00","pubTimestamp":1733047248,"startTime":"0","endTime":"0","summary":"证券之星消息，12月1日华恒生物发布公告《华恒生物:安徽华恒生物科技股份有限公司关于股东集中竞价减持股份结果的公告》，其股东马鞍山基石智能制造产业基金合伙企业(有限合伙)于2024年5月30日至2024年11月29日间合计减持22.1万股，占公司目前总股本的0.0885%，变动期间该股股价下跌48.1%，截止11月29日收盘报35.78元。股东增减持详情见下表：根据华恒生物2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120100001364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2486661369","title":"华恒生物：业绩说明会定于12月9日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2486661369","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486661369?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:46","pubTimestamp":1732779999,"startTime":"0","endTime":"0","summary":"每经AI快讯，华恒生物 11月28日晚间发布公告称，公司2024年第三季度业绩说明会定于2024年12月09日(星期一)下午14:00-15:00，以上证路演中心网络互动的形式进行。2023年1至12月份，华恒生物的营业收入构成为：生物制造行业占比87.92%。华恒生物的总经理、董事长均是郭恒华，女，60岁，学历背景为硕士。截至发稿，华恒生物市值为87亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128154747a25bcb50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128154747a25bcb50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2486044293","title":"华恒生物11月26日收跌0.80% 主力资金逆市抢筹","url":"https://stock-news.laohu8.com/highlight/detail?id=2486044293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486044293?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:20","pubTimestamp":1732605646,"startTime":"0","endTime":"0","summary":"11月26日, 华恒生物股价跌0.80%，报收35.99元，成交金额2.62亿元，换手率3.14%，振幅4.93%，量比1.53。华恒生物今日主力资金净流入3489万元，上一交易日主力净流出1994万元。该股近5个交易日上涨3.93%，主力资金累计净流入1162万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1.57亿元，其中净流出天数为16日。该行业中净流入前三个股分别为康达新材、华恒生物、和远气体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126153340a2566d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126153340a2566d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2486725307","title":"11月25日华恒生物涨5.47%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486725307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486725307?lang=zh_cn&edition=full","pubTime":"2024-11-25 16:11","pubTimestamp":1732522262,"startTime":"0","endTime":"0","summary":"证券之星消息，11月25日华恒生物涨5.47%，收盘报36.28元，换手率3.82%，成交量8.71万手，成交额3.12亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为交银先进制造混合A。交银先进制造混合A目前规模为50.91亿元，最新净值3.6603，较上一交易日下跌2.76%，近一年下跌0.92%。交银先进制造混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500019490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229","399260"],"gpt_icon":0},{"id":"2486077231","title":"华恒生物涨5.47%，华安证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486077231?lang=zh_cn&edition=full","pubTime":"2024-11-25 16:10","pubTimestamp":1732522257,"startTime":"0","endTime":"0","summary":"今日华恒生物涨5.47%，收盘报36.28元。2024年10月30日，华安证券研究员王强峰,刘天其发布了对华恒生物的研报《Q3营收稳定增长业绩承压，关注新产品放量节奏》，该研报对华恒生物给出“买入”评级。维持“买入”评级。此外，天风证券研究员唐婕,张峰，民生证券研究员刘海荣,李金凤近期也对该股发布了研报，同样给出“买入”评级。华恒生物个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500019487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","600909"],"gpt_icon":0},{"id":"2486234717","title":"华恒生物涨5% 券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2486234717","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486234717?lang=zh_cn&edition=full","pubTime":"2024-11-25 11:20","pubTimestamp":1732504858,"startTime":"0","endTime":"0","summary":"11月25日，华恒生物股价大幅上涨，截至11点20分，华恒生物上涨5.23%，报36.20元/股，成交1.50亿元，换手率1.87%，振幅8.20%。资金动向截止发稿，华恒生物获得主力净流出1636万元，其中超大单流出729万元，大单流出905万元。主营业务及业绩华恒生物公司主营业务为氨基酸及其衍生物产品研发、生产、销售。最新财报显示，今年三季报，华恒生物实现营业收入15.39亿元，同比增长12.82%，净利润为1.70亿元，同比减少46.90%，基本每股收益为0.74元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125112106a25345cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125112106a25345cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2484953609","title":"华恒生物11月19日遭主力抛售364万元 环比增加246.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484953609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484953609?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:20","pubTimestamp":1732000805,"startTime":"0","endTime":"0","summary":"11月19日, 华恒生物股价涨2.30%，报收34.63元，成交金额9579万元，换手率1.23%，振幅3.13%，量比0.47。华恒生物今日主力资金净流出364万元，连续5日净流出，上一交易日主力净流出105万元，今日环比增加246.67%。该股近5个交易日下跌10.89%，主力资金累计净流出6536万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1.08亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153143a2450815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153143a2450815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2484050749","title":"皖股这一周｜长信科技拟在越南投资设立全资子公司；华恒生物一副总经理辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2484050749","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484050749?lang=zh_cn&edition=full","pubTime":"2024-11-17 15:56","pubTimestamp":1731830160,"startTime":"0","endTime":"0","summary":"NO.2华恒生物一副总经理辞职11月10日，华恒生物公告，于近日收到公司副总经理唐思青先生提交的书面辞职报告，唐思青因身体原因，申请辞去公司副总经理职务。NO.4长信科技拟在越南投资设立全资子公司11月15日，长信科技发布公告称，公司拟在越南投资设立全资子公司并建设生产基地，计划投资金额不超过2700万美元，拟在越南新设长信科技（越南）有限公司，产品为消费电子、汽车电子模组产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117155629a23f75b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117155629a23f75b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300088","BK0132","688639","BK0188","BK0155","BK0214","BK0070","BK0229","BK0153","BK0028","BK0076","BK0102"],"gpt_icon":0},{"id":"2483582297","title":"华恒生物获得实用新型专利授权：“蒸发釜和蒸发结晶系统”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483582297","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483582297?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:46","pubTimestamp":1731699994,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示华恒生物新获得一项实用新型专利授权，专利名为“蒸发釜和蒸发结晶系统”，专利申请号为CN202322816257.1，授权日为2024年11月1日。今年以来华恒生物新获得专利授权12个，较去年同期减少了52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600010523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2483892014","title":"华恒生物大跌5.02% 2家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483892014","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483892014?lang=zh_cn&edition=full","pubTime":"2024-11-13 11:27","pubTimestamp":1731468424,"startTime":"0","endTime":"0","summary":"11月13日，华恒生物股价大幅下跌，截至11点27分，华恒生物下跌5.02%，报36.91元/股，成交1.55亿元，换手率1.79%。此外，数据统计显示，近半年内2家券商给予增持建议，15家券商给予买入建议。资金动向截止发稿，华恒生物获得主力净流出1124万元，其中超大单流出886万元，大单流出237万元。最新财报显示，今年三季报，华恒生物实现营业收入15.39亿元，同比增长12.82%，净利润为1.70亿元，同比减少46.90%，基本每股收益为0.74元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113112710abbbd085&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113112710abbbd085&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2482721212","title":"华恒生物：目前财务中心管理工作运行稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2482721212","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482721212?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:53","pubTimestamp":1731398014,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问贵公司是否建立财务共享中心，如建立，请问具体是在哪一年？如果没有建立，请问贵公司是否有使用大数据等信息技术进行财务集中核算处理？华恒生物（688639.SH）11月12日在投资者互动平台表示，公司自上市以来建立起了功能比较健全的信息共享制度，目前财务中心管理工作运行稳定，公司将根据业务发展现状与需要，持续提升公司的财务管理水平与业务能力，持续加强信息共享服务建设。(记者 王可然)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112155836a22f9379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112155836a22f9379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2482726024","title":"华恒生物：公司厌氧发酵法规模化生产L-丙氨酸的技术突破，使得 L-丙氨酸产品成本降低约50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726024","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482726024?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:35","pubTimestamp":1731396923,"startTime":"0","endTime":"0","summary":"华恒生物11月12日在投资者互动平台表示，公司厌氧发酵法规模化生产L-丙氨酸的技术突破，使得 L-丙氨酸产品成本降低约50%，同时生产过程更为绿色环保，满足下游客户对原材料的绿色生态标签要求，促进了其在新型绿色螯合剂MGDA领域的规模化应用。公司采用自产的L-丙氨酸制备DL-丙氨酸，采用自产的 β-丙氨酸制备 D-泛酸钙，形成了自有业务的上下游产业链优势，生产成本更加低廉，亦获得了显著的成本优势，具有良好的协同发展效应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112153617a22f7a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112153617a22f7a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2482258273","title":"华恒生物副总经理唐思青辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2482258273","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482258273?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:21","pubTimestamp":1731309660,"startTime":"0","endTime":"0","summary":"11月11日，华恒生物发布公告，近日收到公司副总经理唐思青提交的书面辞职报告，唐思青因身体原因，申请辞去公司副总经理职务。辞职后，唐思青仍为公司核心技术人员并在公司担任技术专家。华恒生物称，唐思青辞职不会影响公司相关工作的正常开展。截至目前，唐思青直接持有公司股份689603股。公开资料显示，华恒生物是一家以合成生物技术为核心，通过生物制造方式，主要从事生物基产品的研发、生产、销售的国家高新技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111152331a22bb119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111152331a22bb119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688639"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","stockEarnings":[{"period":"1week","weight":-0.0955},{"period":"1month","weight":-0.0672},{"period":"3month","weight":0.096},{"period":"6month","weight":-0.4259},{"period":"1year","weight":-0.588},{"period":"ytd","weight":-0.6252}],"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","perCapita":"30749股","boardName":"化学原料和化学制品制造业","registeredCapital":"24972万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":"　　安徽华恒生物科技股份有限公司是从事氨基酸产品的技术研发、生产、销售为一体的高新技术企业。公司主要产品为L-丙氨酸、DL-丙氨酸、β-丙氨酸、L-缬氨酸、D-泛酸钙、D-泛醇、肌醇、1,3-丙二醇、丁二酸、苹果酸、熊果苷。公司先后成功承担了科技部“863”计划、国家发改委微生物制造高技术产业化专项、科技部国家重点研发计划等科技攻关项目。公司的核心技术和产品还获得了多项国家及省部级奖项，例如“中国轻工业联合会技术发明一等奖”、“工信部制造业单项冠军产品”。","serverTime":1734980356668,"listedPrice":23.16,"stockholders":"7426人(较上一季度增加36.71%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}